InvestorsObserver
×
News Home

Will Cannabis Strategic Ventures (NUGS) Stay at the Bottom of the Healthcare Sector?

Monday, October 18, 2021 02:29 PM | InvestorsObserver Analysts

Mentioned in this article

Will Cannabis Strategic Ventures (NUGS) Stay at the Bottom of the Healthcare Sector?

Cannabis Strategic Ventures (NUGS) is around the bottom of the Healthcare sector according to InvestorsObserver. NUGS received an overall rating of 21, which means that it scores higher than 21% of stocks. Additionally, Cannabis Strategic Ventures scored a 10 in the Healthcare sector, ranking it higher than 10% of stocks in that sector.

Overall Score - 21
NUGS has an Overall Score of 21. Find out what this means to you and get the rest of the rankings on NUGS!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies in the healthcare sector can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the best stocks in that sector. Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What's Happening With Cannabis Strategic Ventures Stock Today?

Cannabis Strategic Ventures (NUGS) stock is trading at $0.05 as of 1:54 PM on Monday, Oct 18, a loss of $0.00, or -2.92% from the previous closing price of $0.05. The stock has traded between $0.04 and $0.05 so far today. Volume today is low. So far 479,453 shares have traded compared to average volume of 1,106,059 shares. Click Here to get the full Stock Report for Cannabis Strategic Ventures stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App